| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.862 | 0.002 | 0.907 | Adrenaline uptake inhibitor | 0.907 0.001 DB06700 0.83 0.002 DBMET00055 0.88 0.002 DBMET00437 0.47 0.003 DBMET00967 0.589 0.003 DBMET00958 | DB06700 | |
| 0.82 | 0.004 | 0.864 | Antiadrenergic | 0.864 0.004 DB06700 0.65 0.005 DBMET00055 0.696 0.004 DBMET00437 0.144 0.038 DBMET00967 0.152 0.035 DBMET00958 | DB06700 | |
| 0.818 | 0.004 | 0.862 | Adrenaline antagonist | 0.862 0.004 DB06700 0.645 0.005 DBMET00055 0.69 0.004 DBMET00437 0.14 0.037 DBMET00967 0.147 0.035 DBMET00958 | DB06700 | |
| 0.801 | 0.003 | 0.852 | 5 Hydroxytryptamine uptake inhibitor | 0.852 0.003 DB06700 0.754 0.003 DBMET00055 0.797 0.003 DBMET00437 0.238 0.009 DBMET00967 0.414 0.005 DBMET00958 | DB06700 | |
| 0.745 | 0.009 | 0.825 | Analgesic | 0.825 0.005 DB06700 0.724 0.011 DBMET00055 0.805 0.005 DBMET00437 0.366 0.1 DBMET00967 0.519 0.044 DBMET00958 | DB06700 | |
| 0.701 | 0.006 | 0.717 | Spasmolytic | 0.717 0.005 DB06700 0.556 0.017 DBMET00055 0.58 0.015 DBMET00437 0.59 0.014 DBMET00967 0.682 0.007 DBMET00958 | DB06700 | |
| 0.644 | 0.013 | 0.694 | Aldehyde oxidase inhibitor | 0.694 0.009 DB06700 0.381 0.05 DBMET00055 0.485 0.035 DBMET00437 | DB06700 | |
| 0.573 | 0.005 | 0.587 | Sigma receptor agonist | 0.587 0.005 DB06700 0.534 0.007 DBMET00055 0.546 0.006 DBMET00437 0.179 0.069 DBMET00967 0.196 0.063 DBMET00958 | DB06700 | |
| 0.515 | 0.007 | 0.515 | P-glycoprotein inhibitor | 0.497 0.009 DB06700 0.495 0.009 DBMET00055 0.476 0.01 DBMET00437 0.268 0.036 DBMET00967 0.359 0.02 DBMET00958 | ||
| 0.452 | 0.004 | 0.494 | ABCA1 expression enhancer | 0.494 0.004 DB06700 | DB06700 | |
| 0.442 | 0.005 | 0.442 | Anesthetic local | 0.431 0.005 DB06700 0.286 0.014 DBMET00055 0.279 0.015 DBMET00437 | ||
| 0.424 | 0.014 | 0.437 | Anesthetic general | 0.437 0.012 DB06700 0.333 0.027 DBMET00055 0.348 0.024 DBMET00437 0.393 0.017 DBMET00967 0.324 0.028 DBMET00958 | DB06700 | |
| 0.451 | 0.047 | 0.553 | Immunosuppressant | 0.476 0.039 DB06700 0.37 0.076 DBMET00055 0.391 0.067 DBMET00437 0.553 0.02 DBMET00967 0.532 0.025 DBMET00958 | DBMET00967 | |
| 0.458 | 0.079 | 0.458 | Caspase 9 stimulant | 0.403 0.109 DB06700 0.426 0.096 DBMET00055 0.37 0.13 DBMET00437 0.363 0.136 DBMET00967 0.347 0.148 DBMET00958 | ||
| 0.395 | 0.026 | 0.478 | Calcium channel activator | 0.351 0.049 DB06700 0.478 0.007 DBMET00055 0.439 0.013 DBMET00437 0.218 0.187 DBMET00967 0.24 0.159 DBMET00958 | DBMET00055 | |
| 0.397 | 0.036 | 0.518 | Vasodilator, coronary | 0.354 0.053 DB06700 0.371 0.046 DBMET00055 0.329 0.067 DBMET00437 0.488 0.017 DBMET00967 0.518 0.013 DBMET00958 | DBMET00958 | |
| 0.36 | 0.011 | 0.36 | Alpha adrenoreceptor antagonist | 0.278 0.017 DB06700 0.262 0.019 DBMET00055 0.197 0.028 DBMET00437 | ||
| 0.402 | 0.055 | 0.402 | Vasodilator, peripheral | 0.362 0.069 DB06700 0.305 0.094 DBMET00055 0.267 0.115 DBMET00437 0.196 0.181 DBMET00967 0.247 0.129 DBMET00958 | ||
| 0.327 | 0.017 | 0.343 | Lipocortins synthesis antagonist | 0.343 0.014 DB06700 0.31 0.019 DBMET00055 0.324 0.017 DBMET00437 0.273 0.027 DBMET00967 0.269 0.028 DBMET00958 | DB06700 | |
| 0.359 | 0.061 | 0.648 | Cholesterol antagonist | 0.379 0.054 DB06700 0.313 0.083 DBMET00055 0.328 0.075 DBMET00437 0.648 0.013 DBMET00967 0.614 0.017 DBMET00958 | DBMET00967 | |
| 0.3 | 0.003 | 0.389 | Liver X receptor agonist | 0.389 0.003 DB06700 | DB06700 | |
| 0.301 | 0.011 | 0.301 | Alpha 1 adrenoreceptor antagonist | 0.219 0.018 DB06700 0.226 0.017 DBMET00055 0.156 0.028 DBMET00437 | ||
| 0.282 | 0.004 | 0.296 | Dopamine uptake inhibitor | 0.296 0.004 DB06700 0.24 0.005 DBMET00055 0.252 0.005 DBMET00437 | DB06700 | |
| 0.292 | 0.035 | 0.297 | 5 Hydroxytryptamine 1E antagonist | 0.297 0.032 DB06700 0.285 0.041 DBMET00055 0.289 0.037 DBMET00437 | DB06700 | |
| 0.252 | 0.012 | 0.252 | Alpha 1a adrenoreceptor antagonist | 0.18 0.019 DB06700 0.194 0.017 DBMET00055 0.132 0.026 DBMET00437 | ||
| 0.244 | 0.005 | 0.244 | Sphingomyelinase inhibitor | 0.194 0.011 DB06700 0.238 0.005 DBMET00055 0.188 0.012 DBMET00437 0.142 0.028 DBMET00967 0.176 0.015 DBMET00958 | ||
| 0.302 | 0.077 | 0.337 | Sodium/bile acid cotransporter inhibitor | 0.329 0.055 DB06700 0.314 0.067 DBMET00055 0.337 0.048 DBMET00437 0.255 0.123 DBMET00967 0.278 0.1 DBMET00958 | DBMET00437 | |
| 0.234 | 0.014 | 0.275 | Nav1.1 sodium channel blocker | 0.275 0.01 DB06700 0.213 0.016 DBMET00055 0.246 0.012 DBMET00437 | DB06700 | |
| 0.236 | 0.024 | 0.296 | Cholinergic antagonist | 0.296 0.015 DB06700 0.199 0.032 DBMET00055 0.252 0.02 DBMET00437 | DB06700 | |
| 0.262 | 0.054 | 0.309 | Psychostimulant | 0.276 0.049 DB06700 0.283 0.047 DBMET00055 0.299 0.043 DBMET00437 0.228 0.067 DBMET00967 0.309 0.04 DBMET00958 | DBMET00958 | |
| 0.243 | 0.046 | 0.254 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.254 0.041 DB06700 0.165 0.116 DBMET00055 0.171 0.105 DBMET00437 0.167 0.113 DBMET00967 | DB06700 | |
| 0.209 | 0.012 | 0.209 | Calcium antagonist | 0.114 0.039 DB06700 0.112 0.039 DBMET00055 | ||
| 0.221 | 0.026 | 0.278 | Acetylcholine antagonist | 0.278 0.016 DB06700 0.185 0.035 DBMET00055 0.239 0.022 DBMET00437 | DB06700 | |
| 0.264 | 0.068 | 0.292 | 5 Hydroxytryptamine uptake stimulant | 0.287 0.052 DB06700 0.268 0.065 DBMET00055 0.292 0.049 DBMET00437 | DBMET00437 | |
| 0.266 | 0.078 | 0.266 | Ca(v)3.3 blocker | 0.251 0.099 DB06700 0.233 0.128 DBMET00055 0.212 0.166 DBMET00437 | ||
| 0.22 | 0.034 | 0.273 | Acetylcholine M1 receptor antagonist | 0.273 0.02 DB06700 0.18 0.052 DBMET00055 0.23 0.031 DBMET00437 | DB06700 | |
| 0.207 | 0.027 | 0.213 | Arachidonic acid antagonist | 0.213 0.022 DB06700 0.178 0.056 DBMET00055 0.186 0.047 DBMET00437 0.123 0.122 DBMET00967 | DB06700 | |
| 0.21 | 0.03 | 0.36 | ATPase inhibitor | 0.214 0.027 DB06700 0.214 0.027 DBMET00055 0.218 0.025 DBMET00437 0.292 0.007 DBMET00967 0.36 0.004 DBMET00958 | DBMET00958 | |
| 0.282 | 0.105 | 0.678 | Transcription factor NF kappa B inhibitor | 0.302 0.093 DB06700 0.318 0.086 DBMET00055 0.35 0.077 DBMET00437 0.675 0.024 DBMET00967 0.678 0.023 DBMET00958 | DBMET00958 | |
| 0.188 | 0.016 | 0.214 | Mucolytic | 0.173 0.021 DB06700 0.171 0.022 DBMET00055 0.157 0.029 DBMET00437 0.214 0.01 DBMET00967 0.167 0.024 DBMET00958 | DBMET00967 | |
| 0.226 | 0.054 | 0.312 | Neurotrophic factor enhancer | 0.282 0.024 DB06700 0.247 0.04 DBMET00055 0.305 0.017 DBMET00437 0.307 0.016 DBMET00967 0.312 0.015 DBMET00958 | DBMET00958 | |
| 0.192 | 0.026 | 0.245 | Acetylcholine muscarinic antagonist | 0.243 0.015 DB06700 0.194 0.026 DBMET00055 0.245 0.015 DBMET00437 | DBMET00437 | |
| 0.234 | 0.072 | 0.266 | Cyclic AMP phosphodiesterase inhibitor | 0.228 0.075 DB06700 0.266 0.056 DBMET00967 0.251 0.063 DBMET00958 | DBMET00967 | |
| 0.185 | 0.025 | 0.185 | Nav1.6 sodium channel blocker | 0.179 0.029 DB06700 0.163 0.041 DBMET00055 0.157 0.046 DBMET00437 | ||
| 0.198 | 0.042 | 0.483 | Melanin inhibitor | 0.201 0.04 DB06700 0.191 0.045 DBMET00055 0.194 0.043 DBMET00437 0.483 0.008 DBMET00967 0.352 0.016 DBMET00958 | DBMET00967 | |
| 0.157 | 0.005 | 0.184 | Dopamine transporter inhibitor | 0.175 0.005 DB06700 0.166 0.005 DBMET00055 0.184 0.005 DBMET00437 0.067 0.022 DBMET00958 | DBMET00437 | |
| 0.177 | 0.026 | 0.526 | Expectorant | 0.155 0.033 DB06700 0.167 0.029 DBMET00055 0.144 0.038 DBMET00437 0.526 0.003 DBMET00967 0.426 0.004 DBMET00958 | DBMET00967 | |
| 0.167 | 0.023 | 0.183 | Antineoplastic alkaloid | 0.183 0.019 DB06700 0.093 0.053 DBMET00055 0.1 0.047 DBMET00437 | DB06700 | |
| 0.231 | 0.089 | 0.311 | Tyrosine 3 hydroxylase inhibitor | 0.302 0.032 DB06700 0.238 0.08 DBMET00055 0.311 0.028 DBMET00437 | DBMET00437 | |
| 0.156 | 0.023 | 0.43 | NMDA receptor antagonist | 0.343 0.005 DB06700 0.205 0.014 DBMET00055 0.43 0.004 DBMET00437 | DBMET00437 | |
| 0.148 | 0.018 | 0.148 | Acetylcholine release stimulant | 0.125 0.04 DB06700 0.145 0.019 DBMET00055 0.123 0.044 DBMET00437 0.112 0.062 DBMET00967 0.131 0.033 DBMET00958 | ||
| 0.15 | 0.02 | 0.167 | Acetylcholine nicotinic antagonist | 0.167 0.017 DB06700 0.148 0.021 DBMET00055 0.165 0.017 DBMET00437 | DB06700 | |
| 0.173 | 0.045 | 0.173 | Nav1.2 sodium channel blocker | 0.17 0.047 DB06700 0.162 0.05 DBMET00055 0.159 0.052 DBMET00437 | ||
| 0.196 | 0.069 | 0.219 | 5 Hydroxytryptamine 3E antagonist | 0.217 0.039 DB06700 0.198 0.066 DBMET00055 0.219 0.037 DBMET00437 | DBMET00437 | |
| 0.16 | 0.041 | 0.16 | 5 Hydroxytryptamine 2 antagonist | 0.127 0.054 DB06700 0.102 0.07 DBMET00055 | ||
| 0.197 | 0.079 | 0.215 | Amyloid beta aggregation inhibitor | 0.215 0.07 DB06700 0.136 0.12 DBMET00055 0.145 0.112 DBMET00437 | DB06700 | |
| 0.143 | 0.025 | 0.202 | Prolactin inhibitor | 0.202 0.008 DB06700 0.094 0.062 DBMET00055 0.146 0.024 DBMET00437 | DB06700 | |
| 0.124 | 0.009 | 0.14 | Estrogen-related receptor beta agonist | 0.14 0.005 DB06700 0.098 0.027 DBMET00055 0.11 0.016 DBMET00437 | DB06700 | |
| 0.159 | 0.049 | 0.201 | Adenylate cyclase stimulant | 0.185 0.022 DB06700 0.174 0.031 DBMET00055 0.201 0.013 DBMET00437 0.141 0.078 DBMET00967 0.145 0.072 DBMET00958 | DBMET00437 | |
| 0.147 | 0.041 | 0.17 | Vanilloid 1 agonist | 0.141 0.049 DB06700 0.17 0.023 DBMET00055 0.162 0.028 DBMET00437 0.141 0.049 DBMET00967 0.148 0.04 DBMET00958 | DBMET00055 | |
| 0.137 | 0.032 | 0.137 | 5 Hydroxytryptamine 2A antagonist | 0.11 0.042 DB06700 0.077 0.061 DBMET00055 | ||
| 0.226 | 0.123 | 0.226 | Hypoxia-inducible factor 1 alpha inhibitor | 0.211 0.139 DB06700 0.215 0.134 DBMET00055 0.2 0.152 DBMET00437 0.188 0.167 DBMET00967 0.226 0.122 DBMET00958 | ||
| 0.142 | 0.049 | 0.151 | Cholesterol synthesis inhibitor | 0.151 0.044 DB06700 | DB06700 | |
| 0.109 | 0.016 | 0.218 | Acetylcholine M3 receptor antagonist | 0.188 0.008 DB06700 0.14 0.012 DBMET00055 0.218 0.005 DBMET00437 | DBMET00437 | |
| 0.126 | 0.034 | 0.153 | Anabolic | 0.153 0.016 DB06700 0.112 0.048 DBMET00055 0.141 0.023 DBMET00437 0.088 0.082 DBMET00967 | DB06700 | |
| 0.097 | 0.006 | 0.097 | Calcium channel P-type blocker | 0.066 0.037 DB06700 0.073 0.023 DBMET00055 | ||
| 0.145 | 0.056 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.155 0.033 DB06700 0.136 0.09 DBMET00055 0.145 0.056 DBMET00437 0.152 0.039 DBMET00967 0.141 0.071 DBMET00958 | DB06700 | |
| 0.161 | 0.074 | 0.25 | Interleukin 6 antagonist | 0.171 0.063 DB06700 0.131 0.124 DBMET00055 0.136 0.114 DBMET00437 0.25 0.023 DBMET00967 0.212 0.034 DBMET00958 | DBMET00967 | |
| 0.167 | 0.08 | 0.19 | Tumour necrosis factor antagonist | 0.19 0.059 DBMET00055 | DBMET00055 | |
| 0.117 | 0.032 | 0.159 | Histamine N-methyltransferase inhibitor | 0.159 0.011 DB06700 0.122 0.028 DBMET00437 | DB06700 | |
| 0.132 | 0.049 | 0.137 | Alpha 2b adrenoreceptor antagonist | 0.117 0.06 DB06700 0.137 0.045 DBMET00055 0.123 0.056 DBMET00437 | DBMET00055 | |
| 0.095 | 0.016 | 0.095 | 5 Hydroxytryptamine 1A agonist | 0.093 0.017 DB06700 0.095 0.016 DBMET00055 0.093 0.017 DBMET00437 | ||
| 0.081 | 0.005 | 0.086 | GABA uptake inhibitor | 0.086 0.005 DB06700 0.048 0.017 DBMET00055 0.052 0.014 DBMET00437 | DB06700 | |
| 0.142 | 0.066 | 0.156 | Calcium channel blocker | 0.156 0.053 DBMET00055 0.114 0.095 DBMET00437 | DBMET00055 | |
| 0.102 | 0.027 | 0.102 | Acetylcholine M4 receptor antagonist | 0.096 0.032 DB06700 0.073 0.054 DBMET00055 0.066 0.062 DBMET00437 | ||
| 0.094 | 0.022 | 0.1 | 5 Hydroxytryptamine 1 agonist | 0.1 0.021 DB06700 0.074 0.027 DBMET00055 0.075 0.026 DBMET00437 | DB06700 | |
| 0.119 | 0.049 | 0.119 | Electron transport complex I inhibitor | 0.108 0.066 DBMET00055 | ||
| 0.123 | 0.057 | 0.158 | Microtubule formation inhibitor | 0.108 0.078 DB06700 0.133 0.048 DBMET00055 0.116 0.066 DBMET00437 0.136 0.046 DBMET00967 0.158 0.034 DBMET00958 | DBMET00958 | |
| 0.12 | 0.054 | 0.192 | Estrogen antagonist | 0.192 0.014 DB06700 0.108 0.078 DBMET00055 0.157 0.021 DBMET00437 | DB06700 | |
| 0.234 | 0.168 | 0.418 | Histamine release inhibitor | 0.302 0.123 DB06700 0.229 0.172 DBMET00437 0.418 0.066 DBMET00967 0.395 0.078 DBMET00958 | DBMET00967 | |
| 0.076 | 0.011 | 0.076 | Ryanodine receptor antagonist | 0.059 0.04 DB06700 0.072 0.015 DBMET00055 0.056 0.05 DBMET00437 | ||
| 0.128 | 0.066 | 0.131 | Nav1.3 sodium channel blocker | 0.117 0.078 DB06700 0.131 0.062 DBMET00055 0.12 0.074 DBMET00437 | DBMET00055 | |
| 0.074 | 0.015 | 0.187 | NMDA receptor subunit 3B antagonist | 0.187 0.005 DB06700 0.061 0.019 DBMET00055 0.165 0.005 DBMET00437 | DB06700 | |
| 0.103 | 0.046 | 0.103 | Ca(v)2.2 blocker | 0.1 0.049 DB06700 0.082 0.063 DBMET00055 0.076 0.069 DBMET00437 | ||
| 0.182 | 0.126 | 0.414 | Peptidyltransferase inhibitor | 0.225 0.071 DB06700 0.257 0.046 DBMET00055 0.293 0.027 DBMET00437 0.414 0.006 DBMET00967 0.411 0.006 DBMET00958 | DBMET00967 | |
| 0.087 | 0.032 | 0.087 | Calcium channel L-type blocker | 0.073 0.048 DBMET00055 | ||
| 0.093 | 0.038 | 0.127 | Na+ K+ transporting ATPase inhibitor | 0.106 0.027 DB06700 0.078 0.052 DBMET00437 0.127 0.013 DBMET00967 0.11 0.023 DBMET00958 | DBMET00967 | |
| 0.19 | 0.138 | 0.229 | Neuropeptide Y2 antagonist | 0.229 0.078 DB06700 0.19 0.139 DBMET00437 | DB06700 | |
| 0.093 | 0.042 | 0.109 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.109 0.033 DB06700 | DB06700 | |
| 0.19 | 0.139 | 0.377 | DNA synthesis inhibitor | 0.222 0.092 DB06700 0.185 0.146 DBMET00437 0.377 0.025 DBMET00967 0.326 0.036 DBMET00958 | DBMET00967 | |
| 0.121 | 0.071 | 0.202 | DNA repair enzyme inhibitor | 0.116 0.08 DB06700 0.114 0.086 DBMET00055 0.109 0.097 DBMET00437 0.191 0.01 DBMET00967 0.202 0.009 DBMET00958 | DBMET00958 | |
| 0.261 | 0.214 | 0.478 | 5 Hydroxytryptamine release inhibitor | 0.286 0.181 DB06700 0.265 0.207 DBMET00055 0.291 0.175 DBMET00437 0.478 0.04 DBMET00967 0.357 0.109 DBMET00958 | DBMET00967 | |
| 0.086 | 0.041 | 0.153 | Analgesic, opioid | 0.153 0.014 DB06700 0.078 0.05 DBMET00437 | DB06700 | |
| 0.085 | 0.041 | 0.118 | Estrogen receptor alpha antagonist | 0.118 0.019 DB06700 0.082 0.045 DBMET00437 | DB06700 | |
| 0.077 | 0.032 | 0.077 | Glutamate (mGluR7) antagonist | 0.063 0.057 DB06700 | ||
| 0.182 | 0.138 | 0.314 | 5 Hydroxytryptamine release stimulant | 0.205 0.117 DB06700 0.27 0.08 DBMET00055 0.314 0.066 DBMET00437 0.223 0.104 DBMET00967 0.175 0.146 DBMET00958 | DBMET00437 | |
| 0.138 | 0.096 | 0.316 | Interferon gamma antagonist | 0.149 0.079 DB06700 0.138 0.096 DBMET00055 0.149 0.079 DBMET00437 0.316 0.018 DBMET00967 0.279 0.023 DBMET00958 | DBMET00967 | |
| 0.106 | 0.065 | 0.215 | Topoisomerase I inhibitor | 0.135 0.047 DB06700 0.215 0.023 DBMET00967 0.196 0.027 DBMET00958 | DBMET00967 | |
| 0.063 | 0.023 | 0.227 | Alpha-mannosidase inhibitor | 0.066 0.02 DB06700 0.065 0.021 DBMET00055 0.068 0.018 DBMET00437 0.227 0.003 DBMET00967 0.179 0.003 DBMET00958 | DBMET00967 | |
| 0.126 | 0.087 | 0.271 | Lipid peroxidase inhibitor | 0.169 0.056 DB06700 0.13 0.084 DBMET00437 0.271 0.023 DBMET00967 0.248 0.027 DBMET00958 | DBMET00967 | |
| 0.083 | 0.045 | 0.083 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.065 | 0.027 | 0.079 | Lipocortins synthesis agonist | 0.068 0.024 DB06700 0.062 0.031 DBMET00055 0.065 0.028 DBMET00437 0.079 0.014 DBMET00967 0.075 0.017 DBMET00958 | DBMET00967 | |
| 0.106 | 0.07 | 0.136 | Cystathionine beta-synthase inhibitor | 0.136 0.047 DB06700 0.108 0.069 DBMET00437 0.133 0.049 DBMET00967 | DB06700 | |
| 0.067 | 0.03 | 0.078 | Heme oxygenase stimulant | 0.073 0.021 DB06700 0.072 0.023 DBMET00055 0.078 0.017 DBMET00437 0.062 0.041 DBMET00958 | DBMET00437 | |
| 0.132 | 0.096 | 0.141 | Sphingosine 1-phosphate receptor 5 antagonist | 0.141 0.078 DB06700 0.124 0.114 DBMET00437 | DB06700 | |
| 0.103 | 0.067 | 0.103 | Falcipain 3 inhibitor | 0.093 0.078 DB06700 | ||
| 0.054 | 0.018 | 0.146 | NMDA receptor subunit 3A antagonist | 0.146 0.005 DB06700 0.044 0.023 DBMET00055 0.13 0.006 DBMET00437 | DB06700 | |
| 0.092 | 0.058 | 0.092 | Glutamate release inhibitor | 0.092 0.057 DBMET00055 0.091 0.06 DBMET00967 0.085 0.075 DBMET00958 | ||
| 0.139 | 0.106 | 0.383 | Nitric oxide antagonist | 0.147 0.097 DB06700 0.132 0.117 DBMET00055 0.138 0.108 DBMET00437 0.383 0.028 DBMET00967 0.348 0.032 DBMET00958 | DBMET00967 | |
| 0.048 | 0.015 | 0.057 | Glucocorticoid antagonist | 0.057 0.013 DB06700 0.044 0.017 DBMET00055 0.052 0.014 DBMET00437 | DB06700 | |
| 0.067 | 0.034 | 0.096 | Androgen agonist | 0.096 0.016 DB06700 0.054 0.049 DBMET00055 0.081 0.024 DBMET00437 | DB06700 | |
| 0.244 | 0.212 | 0.567 | Calcium channel L-type activator | 0.339 0.126 DB06700 0.532 0.017 DBMET00055 0.567 0.01 DBMET00437 0.431 0.061 DBMET00958 | DBMET00437 | |
| 0.101 | 0.069 | 0.172 | Toll-Like receptor 4 antagonist | 0.1 0.07 DB06700 0.172 0.012 DBMET00967 0.158 0.017 DBMET00958 | DBMET00967 | |
| 0.055 | 0.024 | 0.055 | Potassium channel Kv1.3 blocker | 0.051 0.028 DBMET00055 | ||
| 0.074 | 0.044 | 0.074 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.158 | 0.129 | 0.264 | Hypolipemic | 0.17 0.118 DB06700 0.219 0.082 DBMET00967 0.264 0.061 DBMET00958 | DBMET00958 | |
| 0.098 | 0.069 | 0.147 | Estrogen receptor beta antagonist | 0.147 0.016 DB06700 0.13 0.023 DBMET00437 | DB06700 | |
| 0.053 | 0.024 | 0.055 | Adenylate cyclase 1 inhibitor | 0.055 0.021 DB06700 | DB06700 | |
| 0.122 | 0.093 | 0.133 | Sphingosine 1-phosphate receptor 2 antagonist | 0.128 0.079 DB06700 0.127 0.08 DBMET00055 0.133 0.068 DBMET00437 | DBMET00437 | |
| 0.144 | 0.116 | 0.432 | Hepatoprotectant | 0.153 0.106 DB06700 0.184 0.077 DBMET00055 0.195 0.068 DBMET00437 0.423 0.011 DBMET00967 0.432 0.011 DBMET00958 | DBMET00958 | |
| 0.12 | 0.093 | 0.349 | Protein kinase stimulant | 0.126 0.086 DB06700 0.152 0.067 DBMET00055 0.16 0.062 DBMET00437 0.349 0.012 DBMET00967 0.299 0.017 DBMET00958 | DBMET00967 | |
| 0.034 | 0.008 | 0.034 | Hedgehog signaling activator | 0.028 0.017 DB06700 0.029 0.014 DBMET00055 | ||
| 0.128 | 0.105 | 0.134 | Neuropeptide Y1 antagonist | 0.134 0.093 DB06700 0.125 0.111 DBMET00437 | DB06700 | |
| 0.171 | 0.149 | 0.222 | Nitric-oxide synthase stimulant | 0.182 0.123 DB06700 0.194 0.099 DBMET00055 0.206 0.08 DBMET00437 0.222 0.057 DBMET00967 0.204 0.082 DBMET00958 | DBMET00967 | |
| 0.1 | 0.078 | 0.1 | 5 Hydroxytryptamine antagonist | |||
| 0.098 | 0.076 | 0.111 | DNA intercalator | 0.111 0.063 DB06700 0.101 0.072 DBMET00967 0.111 0.063 DBMET00958 | DBMET00958 | |
| 0.032 | 0.013 | 0.042 | Estrogen-related receptor gamma antagonist | 0.042 0.004 DB06700 0.034 0.01 DBMET00437 | DB06700 | |
| 0.08 | 0.063 | 0.111 | CC chemokine 5 receptor agonist | 0.111 0.012 DB06700 0.1 0.022 DBMET00437 | DB06700 | |
| 0.046 | 0.03 | 0.252 | Mannosidase inhibitor | 0.05 0.026 DB06700 0.048 0.027 DBMET00055 0.052 0.023 DBMET00437 0.252 0.003 DBMET00967 0.169 0.004 DBMET00958 | DBMET00967 | |
| 0.101 | 0.086 | 0.144 | Photosensitizer | 0.106 0.077 DB06700 0.144 0.035 DBMET00967 0.109 0.073 DBMET00958 | DBMET00967 | |
| 0.12 | 0.105 | 0.278 | Diuretic | 0.172 0.059 DB06700 0.278 0.026 DBMET00967 0.218 0.038 DBMET00958 | DBMET00967 | |
| 0.079 | 0.064 | 0.087 | Ca(v)3.1 blocker | 0.087 0.042 DB06700 0.076 0.074 DBMET00437 | DB06700 | |
| 0.14 | 0.128 | 0.177 | Phospholipase C inhibitor | 0.176 0.065 DB06700 0.146 0.114 DBMET00437 0.177 0.064 DBMET00967 | DBMET00967 | |
| 0.079 | 0.068 | 0.088 | Histamine H2 receptor antagonist | 0.076 0.073 DB06700 0.088 0.051 DBMET00055 0.085 0.054 DBMET00437 | DBMET00055 | |
| 0.036 | 0.027 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.041 0.019 DB06700 | DB06700 | |
| 0.035 | 0.026 | 0.045 | Glutamate (mGluR8) antagonist | 0.038 0.019 DB06700 0.034 0.03 DBMET00055 0.037 0.023 DBMET00437 0.045 0.012 DBMET00967 0.035 0.027 DBMET00958 | DBMET00967 | |
| 0.194 | 0.185 | 0.671 | Antithrombotic | 0.214 0.161 DB06700 0.21 0.165 DBMET00437 0.671 0.01 DBMET00967 0.635 0.013 DBMET00958 | DBMET00967 | |
| 0.037 | 0.03 | 0.037 | Vanilloid 3 antagonist | |||
| 0.05 | 0.044 | 0.061 | Leukotriene B4 antagonist | 0.061 0.026 DBMET00967 0.053 0.039 DBMET00958 | DBMET00967 | |
| 0.152 | 0.145 | 0.23 | Antiamyloidogenic | 0.168 0.125 DBMET00055 0.157 0.137 DBMET00437 0.23 0.081 DBMET00958 | DBMET00958 | |
| 0.035 | 0.029 | 0.036 | Glutamate (mGluR3) antagonist | 0.036 0.026 DB06700 | DB06700 | |
| 0.028 | 0.023 | 0.033 | Liver X receptor alpha antagonist | 0.033 0.015 DB06700 | DB06700 | |
| 0.096 | 0.091 | 0.113 | Calcium channel (voltage-sensitive) blocker | 0.113 0.065 DBMET00055 | DBMET00055 | |
| 0.06 | 0.055 | 0.06 | 5 Hydroxytryptamine agonist | 0.059 0.056 DBMET00055 | ||
| 0.059 | 0.055 | 0.073 | Beta 2 adrenoreceptor agonist | 0.069 0.022 DB06700 0.063 0.039 DBMET00055 0.073 0.015 DBMET00437 | DBMET00437 | |
| 0.038 | 0.034 | 0.044 | Liver X receptor alpha agonist | 0.044 0.024 DB06700 | DB06700 | |
| 0.064 | 0.06 | 0.064 | Dopamine antagonist | |||
| 0.053 | 0.05 | 0.053 | Calcium channel T-type blocker | |||
| 0.015 | 0.012 | 0.017 | Antibiotic Tetracycline-like | 0.017 0.006 DB06700 | DB06700 | |
| 0.056 | 0.054 | 0.056 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.056 | 0.055 | 0.068 | Dopamine D1 antagonist | 0.068 0.042 DB06700 | DB06700 | |
| 0.075 | 0.074 | 0.076 | Alpha 2 adrenoreceptor antagonist | 0.076 0.072 DBMET00055 | DBMET00055 | |
| 0.041 | 0.041 | 0.119 | Estrogen agonist | 0.119 0.014 DB06700 0.092 0.019 DBMET00437 0.054 0.033 DBMET00967 0.05 0.035 DBMET00958 | DB06700 | |
| 0.127 | 0.127 | 0.135 | CF transmembrane conductance regulator agonist | 0.135 0.106 DB06700 | DB06700 | |
| 0.045 | 0.046 | 0.052 | Squalene epoxidase inhibitor | 0.052 0.031 DB06700 | DB06700 | |
| 0.093 | 0.094 | 0.159 | DNA polymerase I inhibitor | 0.127 0.063 DB06700 0.1 0.086 DBMET00437 0.159 0.045 DBMET00967 0.139 0.055 DBMET00958 | DBMET00967 | |
| 0.017 | 0.019 | 0.031 | Antibiotic Anthracycline-like | 0.031 0.003 DBMET00967 0.025 0.005 DBMET00958 | DBMET00967 | |
| 0.093 | 0.097 | 0.203 | Alkylator | 0.104 0.084 DB06700 0.097 0.092 DBMET00437 0.196 0.027 DBMET00967 0.203 0.025 DBMET00958 | DBMET00958 | |
| 0.033 | 0.038 | 0.056 | Estradiol 17 beta-dehydrogenase inhibitor | 0.056 0.021 DB06700 0.036 0.034 DBMET00437 | DB06700 | |
| 0.05 | 0.055 | 0.066 | Acetylcholine M2 receptor antagonist | 0.065 0.041 DB06700 0.066 0.04 DBMET00437 | DBMET00437 | |
| 0.026 | 0.032 | 0.033 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.033 0.021 DB06700 | DB06700 | |
| 0.23 | 0.236 | 0.721 | Cyclophilin D inhibitor | 0.278 0.183 DB06700 0.721 0.012 DBMET00967 0.709 0.013 DBMET00958 | DBMET00967 | |
| 0.024 | 0.032 | 0.031 | Liver X receptor antagonist | 0.031 0.021 DB06700 | DB06700 | |
| 0.021 | 0.028 | 0.027 | Urotensin II agonist | 0.027 0.019 DB06700 | DB06700 | |
| 0.032 | 0.04 | 0.044 | Dopamine D5 antagonist | 0.044 0.029 DB06700 | DB06700 | |
| 0.15 | 0.158 | 0.295 | Vasodilator | 0.28 0.055 DBMET00967 0.295 0.05 DBMET00958 | DBMET00958 | |
| 0.096 | 0.106 | 0.158 | Interleukin 8 antagonist | 0.129 0.051 DB06700 0.117 0.065 DBMET00055 0.158 0.029 DBMET00437 | DBMET00437 | |
| 0.028 | 0.039 | 0.033 | Melatonin receptor 1A agonist | 0.033 0.024 DBMET00055 | DBMET00055 | |
| 0.049 | 0.062 | 0.055 | Acetylcholine M5 receptor antagonist | 0.055 0.051 DB06700 | DB06700 | |
| 0.054 | 0.067 | 0.06 | Beta adrenoreceptor antagonist | 0.059 0.058 DB06700 0.06 0.055 DBMET00437 | DBMET00437 | |
| 0.151 | 0.164 | 0.547 | Antioxidant | 0.199 0.115 DB06700 0.186 0.126 DBMET00437 0.547 0.015 DBMET00967 0.507 0.019 DBMET00958 | DBMET00967 | |
| 0.085 | 0.1 | 0.137 | Adenylate cyclase inhibitor | 0.137 0.054 DB06700 0.103 0.082 DBMET00437 | DB06700 | |
| 0.055 | 0.072 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.059 0.058 DB06700 0.061 0.053 DBMET00055 0.065 0.042 DBMET00437 | DBMET00437 | |
| 0.014 | 0.031 | 0.021 | Estrogen-related receptor gamma agonist | 0.021 0.009 DB06700 0.02 0.01 DBMET00437 | DB06700 | |
| 0.039 | 0.056 | 0.103 | Protein 50S ribosomal subunit inhibitor | 0.103 0.012 DBMET00967 0.1 0.013 DBMET00958 | DBMET00967 | |
| 0.04 | 0.058 | 0.057 | Topoisomerase II beta inhibitor | 0.057 0.024 DB06700 | DB06700 | |
| 0.014 | 0.033 | 0.022 | Corticosteroid-like | 0.022 0.013 DBMET00967 0.021 0.016 DBMET00958 | DBMET00967 | |
| 0.126 | 0.145 | 0.139 | Heat shock protein 70 antagonist | 0.132 0.113 DB06700 0.139 0.079 DBMET00967 | DBMET00967 | |
| 0.069 | 0.089 | 0.095 | MAP kinase kinase 7 inhibitor | 0.093 0.02 DB06700 0.095 0.018 DBMET00437 | DBMET00437 | |
| 0.017 | 0.038 | 0.084 | Estrogen receptor alpha agonist | 0.084 0.011 DB06700 0.061 0.015 DBMET00437 | DB06700 | |
| 0.057 | 0.079 | 0.132 | Topoisomerase II alpha inhibitor | 0.078 0.054 DB06700 0.132 0.027 DBMET00967 0.112 0.033 DBMET00958 | DBMET00967 | |
| 0.027 | 0.051 | 0.081 | Antibiotic Aminoglycoside-like | 0.081 0.004 DBMET00967 0.075 0.005 DBMET00958 | DBMET00967 | |
| 0.041 | 0.066 | 0.082 | Glucose-6-phosphate translocase inhibitor | 0.082 0.01 DBMET00967 0.074 0.014 DBMET00958 | DBMET00967 | |
| 0.025 | 0.052 | 0.039 | Estrogen-related receptor beta antagonist | 0.039 0.012 DB06700 | DB06700 | |
| 0.127 | 0.157 | 0.294 | Non-steroidal antiinflammatory agent | 0.294 0.029 DBMET00967 0.278 0.033 DBMET00958 | DBMET00967 | |
| 0.016 | 0.047 | 0.025 | Liver X receptor beta antagonist | 0.025 0.024 DB06700 | DB06700 | |
| 0.015 | 0.046 | 0.064 | Protein 30S ribosomal subunit inhibitor | 0.064 0.005 DBMET00967 0.057 0.007 DBMET00958 | DBMET00967 | |
| 0.045 | 0.078 | 0.234 | Phosphofructokinase-1 inhibitor | 0.082 0.04 DB06700 0.069 0.048 DBMET00437 0.234 0.008 DBMET00967 0.158 0.017 DBMET00958 | DBMET00967 | |
| 0.06 | 0.094 | 0.094 | Androgen antagonist | 0.094 0.051 DB06700 0.085 0.059 DBMET00437 | DB06700 | |
| 0.08 | 0.117 | 0.126 | GABA C receptor antagonist | 0.125 0.047 DB06700 0.126 0.047 DBMET00437 | DBMET00437 | |
| 0.072 | 0.109 | 0.089 | T cell inhibitor | 0.089 0.04 DBMET00967 0.087 0.045 DBMET00958 | DBMET00967 | |
| 0.017 | 0.057 | 0.037 | Vanilloid 2 agonist | 0.024 0.022 DB06700 0.035 0.005 DBMET00967 0.037 0.005 DBMET00958 | DBMET00958 | |
| 0.074 | 0.117 | 0.182 | Topoisomerase II inhibitor | 0.105 0.081 DB06700 0.182 0.038 DBMET00967 0.166 0.043 DBMET00958 | DBMET00967 | |
| 0.142 | 0.186 | 0.205 | DNA damaging | 0.18 0.134 DBMET00055 0.181 0.133 DBMET00437 0.164 0.153 DBMET00967 0.205 0.111 DBMET00958 | DBMET00958 | |
| 0.023 | 0.068 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.025 DBMET00437 | DBMET00437 | |
| 0.07 | 0.115 | 0.126 | GABA C receptor agonist | 0.118 0.051 DB06700 0.126 0.045 DBMET00437 0.088 0.082 DBMET00967 | DBMET00437 | |
| 0.061 | 0.107 | 0.072 | GABA B receptor agonist | 0.072 0.061 DBMET00437 | DBMET00437 | |
| 0.07 | 0.117 | 0.092 | Carbonic anhydrase III inhibitor | 0.092 0.071 DB06700 | DB06700 | |
| 0.082 | 0.13 | 0.103 | Calcium channel N-type blocker | 0.103 0.09 DBMET00055 | DBMET00055 | |
| 0.114 | 0.163 | 0.142 | Antipruritic | 0.138 0.109 DB06700 0.142 0.103 DBMET00437 | DBMET00437 | |
| 0.023 | 0.075 | 0.054 | Dopamine D5 agonist | 0.053 0.016 DB06700 0.054 0.015 DBMET00437 | DBMET00437 | |
| 0.042 | 0.095 | 0.196 | Antineoplastic antibiotic | 0.196 0.022 DBMET00967 0.172 0.026 DBMET00958 | DBMET00967 | |
| 0.01 | 0.062 | 0.035 | Squalene synthetase inhibitor | 0.035 0.02 DBMET00967 0.03 0.023 DBMET00958 | DBMET00967 | |
| 0.056 | 0.109 | 0.078 | Myeloperoxidase inhibitor | 0.078 0.07 DBMET00437 | DBMET00437 | |
| 0.03 | 0.084 | 0.047 | Acyl-CoA dehydrogenase inhibitor | 0.047 0.046 DB06700 | DB06700 | |
| 0.17 | 0.225 | 0.211 | Caspase 3 stimulant | 0.211 0.154 DBMET00967 0.205 0.162 DBMET00958 | DBMET00967 | |
| 0.052 | 0.114 | 0.082 | Glycine receptor agonist | 0.082 0.036 DBMET00967 | DBMET00967 | |
| 0.029 | 0.092 | 0.046 | Histamine H1 receptor agonist | 0.046 0.024 DBMET00437 | DBMET00437 | |
| 0.008 | 0.072 | 0.056 | Estrogen receptor beta agonist | 0.056 0.018 DB06700 | DB06700 | |
| 0.039 | 0.104 | 0.067 | Neuronal nicotinic receptor antagonist | 0.067 0.047 DBMET00437 | DBMET00437 | |
| 0.024 | 0.091 | 0.046 | Histamine H2 receptor agonist | 0.046 0.026 DBMET00437 | DBMET00437 | |
| 0.052 | 0.121 | 0.072 | Interferon agonist | 0.072 0.066 DBMET00967 | DBMET00967 | |
| 0.049 | 0.119 | 0.109 | GABA aminotransferase inhibitor | 0.071 0.059 DB06700 0.109 0.021 DBMET00967 | DBMET00967 | |
| 0.034 | 0.104 | 0.047 | Beta adrenoreceptor agonist | 0.047 0.026 DBMET00437 | DBMET00437 | |
| 0.078 | 0.149 | 0.298 | Cyclooxygenase 3 inhibitor | 0.298 0.006 DBMET00967 0.217 0.014 DBMET00958 | DBMET00967 | |
| 0.052 | 0.124 | 0.101 | Glycine receptor antagonist | 0.1 0.032 DBMET00967 0.101 0.031 DBMET00958 | DBMET00958 | |
| 0.011 | 0.083 | 0.057 | Sodium/glucose cotransporter 2 inhibitor | 0.057 0.005 DBMET00967 0.04 0.008 DBMET00958 | DBMET00967 | |
| 0.086 | 0.159 | 0.119 | Transcription factor STAT6 inhibitor | 0.119 0.062 DB06700 0.118 0.064 DBMET00437 | DB06700 | |
| 0.072 | 0.145 | 0.087 | Phosphodiesterase 6D inhibitor | 0.087 0.085 DBMET00967 0.087 0.085 DBMET00958 | DBMET00958 | |
| 0.049 | 0.123 | 0.12 | Adrenaline agonist | 0.077 0.061 DB06700 0.081 0.057 DBMET00055 0.12 0.025 DBMET00437 | DBMET00437 | |
| 0.007 | 0.089 | 0.02 | Telomerase stimulant | 0.02 0.007 DBMET00967 | DBMET00967 | |
| 0.059 | 0.146 | 0.142 | NADH dehydrogenase inhibitor | 0.142 0.02 DBMET00967 0.1 0.044 DBMET00958 | DBMET00967 | |
| 0.05 | 0.138 | 0.09 | Opioid kappa receptor antagonist | 0.08 0.057 DB06700 0.09 0.045 DBMET00437 | DBMET00437 | |
| 0.044 | 0.136 | 0.079 | Glutamate dehydrogenase inhibitor | 0.075 0.05 DBMET00437 0.079 0.046 DBMET00967 | DBMET00967 | |
| 0.012 | 0.105 | 0.051 | Sodium/glucose cotransporter inhibitor | 0.051 0.005 DBMET00967 0.05 0.005 DBMET00958 | DBMET00967 | |
| 0.01 | 0.103 | 0.022 | Motilin receptor agonist | 0.022 0.017 DBMET00958 | DBMET00958 | |
| 0.017 | 0.11 | 0.041 | Oxytocin agonist | 0.038 0.034 DB06700 0.041 0.031 DBMET00437 | DBMET00437 | |
| 0.032 | 0.126 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.039 DB06700 | DB06700 | |
| 0.107 | 0.206 | 0.506 | Immunostimulant | 0.164 0.143 DB06700 0.506 0.028 DBMET00967 0.438 0.039 DBMET00958 | DBMET00967 | |
| 0.027 | 0.127 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 DBMET00967 0.045 0.039 DBMET00958 | DBMET00967 | |
| 0.068 | 0.168 | 0.104 | Glutamate (mGluR7) agonist | 0.104 0.052 DBMET00055 | DBMET00055 | |
| 0.109 | 0.21 | 0.469 | Free radical scavenger | 0.469 0.019 DBMET00967 0.437 0.023 DBMET00958 | DBMET00967 | |
| 0.024 | 0.126 | 0.046 | Beta 2 adrenoreceptor antagonist | 0.046 0.043 DBMET00437 | DBMET00437 | |
| 0.01 | 0.113 | 0.038 | Complement C3a chemotactic receptor antagonist | 0.038 0.034 DBMET00437 | DBMET00437 | |
| 0.047 | 0.15 | 0.112 | Opioid antagonist | 0.089 0.057 DB06700 0.112 0.04 DBMET00437 | DBMET00437 | |
| 0.042 | 0.146 | 0.087 | Ornithine decarboxylase inhibitor | 0.086 0.061 DBMET00437 0.087 0.059 DBMET00967 | DBMET00967 | |
| 0.1 | 0.204 | 0.157 | Anticonvulsant | 0.157 0.121 DBMET00437 | DBMET00437 | |
| 0.155 | 0.262 | 0.412 | Apoptosis antagonist | 0.202 0.176 DBMET00055 0.226 0.15 DBMET00437 0.41 0.035 DBMET00967 0.412 0.035 DBMET00958 | DBMET00958 | |
| 0.114 | 0.222 | 0.144 | Neurotensin receptor agonist | 0.144 0.117 DBMET00437 | DBMET00437 | |
| 0.06 | 0.172 | 0.116 | Glutamate receptor antagonist | 0.116 0.079 DB06700 0.106 0.089 DBMET00437 | DB06700 | |
| 0.023 | 0.137 | 0.045 | Microtubule stabilization | 0.044 0.036 DBMET00967 0.045 0.035 DBMET00958 | DBMET00958 | |
| 0.064 | 0.183 | 0.221 | Alpha-N-acetylglucosaminidase inhibitor | 0.11 0.089 DBMET00437 0.221 0.029 DBMET00967 0.206 0.032 DBMET00958 | DBMET00967 | |
| 0.047 | 0.168 | 0.141 | Mediator release inhibitor | 0.141 0.033 DBMET00967 0.131 0.039 DBMET00958 | DBMET00967 | |
| 0.073 | 0.194 | 0.136 | Peroxidase inhibitor | 0.136 0.086 DB06700 0.136 0.086 DBMET00437 | DBMET00437 | |
| 0.105 | 0.23 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.046 DBMET00967 0.137 0.048 DBMET00958 | DBMET00958 | |
| 0.022 | 0.152 | 0.079 | Opioid mu receptor antagonist | 0.059 0.055 DB06700 0.079 0.04 DBMET00437 | DBMET00437 | |
| 0.081 | 0.214 | 0.218 | Hexokinase inhibitor | 0.218 0.026 DBMET00967 0.177 0.051 DBMET00958 | DBMET00967 | |
| 0.059 | 0.193 | 0.092 | Nav1.4 sodium channel blocker | 0.092 0.089 DB06700 | DB06700 | |
| 0.087 | 0.221 | 0.141 | GABA C receptor rho-2 antagonist | 0.141 0.087 DBMET00437 | DBMET00437 | |
| 0.014 | 0.149 | 0.098 | NMDA 2A receptor antagonist | 0.098 0.014 DBMET00437 | DBMET00437 | |
| 0.031 | 0.168 | 0.052 | Factor III inhibitor | 0.052 0.029 DBMET00967 0.047 0.043 DBMET00958 | DBMET00967 | |
| 0.155 | 0.291 | 0.636 | Antibacterial | 0.221 0.206 DB06700 0.252 0.175 DBMET00437 0.636 0.015 DBMET00967 0.628 0.015 DBMET00958 | DBMET00967 | |
| 0.037 | 0.174 | 0.27 | Monophenol monooxygenase inhibitor | 0.27 0.021 DBMET00967 0.146 0.049 DBMET00958 | DBMET00967 | |
| 0.063 | 0.203 | 0.097 | DOPA decarboxylase inhibitor | 0.097 0.083 DB06700 | DB06700 | |
| 0.048 | 0.192 | 0.193 | UDP-glucose 4-epimerase inhibitor | 0.193 0.019 DBMET00967 0.148 0.029 DBMET00958 | DBMET00967 | |
| 0.044 | 0.196 | 0.121 | Creatine kinase inhibitor | 0.121 0.04 DB06700 0.103 0.056 DBMET00437 | DB06700 | |
| 0.058 | 0.21 | 0.16 | Toll-Like receptor 3 antagonist | 0.16 0.012 DBMET00055 0.139 0.018 DBMET00437 | DBMET00055 | |
| 0.016 | 0.172 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 DBMET00967 0.029 0.014 DBMET00958 | DBMET00958 | |
| 0.004 | 0.168 | 0.064 | Arginase inhibitor | 0.064 0.009 DBMET00967 0.043 0.02 DBMET00958 | DBMET00967 | |
| 0.07 | 0.235 | 0.318 | Cell wall synthesis inhibitor | 0.125 0.092 DBMET00437 0.318 0.009 DBMET00967 0.284 0.011 DBMET00958 | DBMET00967 | |
| 0.046 | 0.212 | 0.168 | Triose-phosphate isomerase inhibitor | 0.168 0.016 DBMET00967 0.105 0.043 DBMET00958 | DBMET00967 | |
| 0.131 | 0.301 | 0.207 | Insulysin inhibitor | 0.187 0.177 DB06700 0.207 0.146 DBMET00437 | DBMET00437 | |
| 0.015 | 0.188 | 0.116 | NMDA 2 receptor antagonist | 0.116 0.025 DBMET00437 | DBMET00437 | |
| 0.046 | 0.221 | 0.099 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 DBMET00967 | DBMET00967 | |
| 0.048 | 0.223 | 0.094 | GABA C receptor rho-1 antagonist | 0.094 0.071 DBMET00437 | DBMET00437 | |
| 0.084 | 0.265 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.06 DBMET00437 | DBMET00437 | |
| 0.007 | 0.191 | 0.022 | Dopamine D1 agonist | 0.022 0.018 DBMET00967 | DBMET00967 | |
| 0.039 | 0.225 | 0.108 | ATPase (Vacuolar H+) inhibitor | 0.108 0.03 DBMET00967 0.106 0.032 DBMET00958 | DBMET00967 | |
| 0.047 | 0.236 | 0.315 | Amylase inhibitor | 0.315 0.016 DBMET00967 0.199 0.045 DBMET00958 | DBMET00967 | |
| 0.133 | 0.325 | 0.284 | GABA C receptor rho-3 antagonist | 0.266 0.141 DB06700 0.284 0.127 DBMET00437 | DBMET00437 | |
| 0.153 | 0.352 | 0.485 | Apoptosis agonist | 0.431 0.099 DBMET00967 0.485 0.079 DBMET00958 | DBMET00958 | |
| 0.048 | 0.25 | 0.131 | Transcription factor NF kappa B stimulant | 0.131 0.021 DBMET00967 0.129 0.022 DBMET00958 | DBMET00967 | |
| 0.044 | 0.248 | 0.152 | Beta glucuronidase inhibitor | 0.152 0.024 DBMET00967 0.126 0.04 DBMET00958 | DBMET00967 | |
| 0.02 | 0.23 | 0.093 | Phenylalanine 4-hydroxylase inhibitor | 0.093 0.029 DBMET00437 | DBMET00437 | |
| 0.007 | 0.228 | 0.025 | Factor IX inhibitor | 0.022 0.01 DBMET00055 0.025 0.008 DBMET00437 | DBMET00437 | |
| 0.062 | 0.305 | 0.317 | Interleukin agonist | 0.317 0.04 DBMET00967 0.26 0.072 DBMET00958 | DBMET00967 | |
| 0.006 | 0.272 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DBMET00967 | DBMET00967 | |
| 0.008 | 0.276 | 0.048 | Purinergic P2X7 antagonist | 0.039 0.022 DBMET00055 0.048 0.015 DBMET00437 | DBMET00437 | |
| 0.081 | 0.35 | 0.577 | Hypoglycemic | 0.577 0.009 DBMET00967 0.521 0.014 DBMET00958 | DBMET00967 | |
| 0.036 | 0.309 | 0.321 | Thrombolytic | 0.321 0.021 DBMET00967 0.241 0.036 DBMET00958 | DBMET00967 | |
| 0.065 | 0.345 | 0.304 | Tumour necrosis factor alpha release inhibitor | 0.279 0.062 DBMET00967 0.304 0.052 DBMET00958 | DBMET00958 | |
| 0.029 | 0.309 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.031 DBMET00967 0.054 0.044 DBMET00958 | DBMET00967 | |
| 0.043 | 0.329 | 0.65 | Angiogenesis stimulant | 0.65 0.005 DBMET00967 0.567 0.008 DBMET00958 | DBMET00967 | |
| 0.021 | 0.308 | 0.129 | Factor IXa inhibitor | 0.088 0.013 DBMET00055 0.101 0.01 DBMET00437 0.093 0.012 DBMET00967 0.129 0.005 DBMET00958 | DBMET00958 | |
| 0.012 | 0.311 | 0.342 | Selectin antagonist | 0.342 0.004 DBMET00967 0.329 0.004 DBMET00958 | DBMET00967 | |
| 0.012 | 0.318 | 0.053 | Neuraminidase (Influenza A) inhibitor | 0.053 0.02 DBMET00967 0.044 0.035 DBMET00958 | DBMET00967 | |
| 0.03 | 0.337 | 0.161 | AMP-activated protein kinase stimulant | 0.161 0.022 DBMET00967 0.143 0.033 DBMET00958 | DBMET00967 | |
| 0.018 | 0.334 | 0.068 | Heparanase inhibitor | 0.068 0.013 DBMET00967 0.064 0.017 DBMET00958 | DBMET00967 | |
| 0.049 | 0.414 | 0.22 | Insulin secretagoues | 0.22 0.027 DBMET00967 0.197 0.037 DBMET00958 | DBMET00967 | |
| 0.044 | 0.414 | 0.344 | Platelet adhesion inhibitor | 0.344 0.021 DBMET00967 0.298 0.035 DBMET00958 | DBMET00967 | |
| 0.009 | 0.4 | 0.053 | Purinergic P2X antagonist | 0.046 0.037 DBMET00055 0.053 0.029 DBMET00437 | DBMET00437 | |
| 0.012 | 0.439 | 0.11 | Protein kinase A inhibitor | 0.08 0.06 DBMET00055 0.11 0.039 DBMET00437 | DBMET00437 | |
| 0.04 | 0.492 | 0.091 | Interleukin 12 antagonist | 0.091 0.071 DBMET00967 | DBMET00967 | |
| 0.024 | 0.492 | 0.09 | Thioredoxin inhibitor | 0.09 0.061 DBMET00967 0.082 0.077 DBMET00958 | DBMET00967 | |
| 0.086 | 0.557 | 0.43 | Interleukin 2 agonist | 0.43 0.02 DBMET00967 0.376 0.035 DBMET00958 | DBMET00967 | |
| 0.042 | 0.534 | 0.224 | NOS3 expression enhancer | 0.224 0.033 DBMET00967 0.187 0.046 DBMET00958 | DBMET00967 | |
| 0.009 | 0.507 | 0.074 | Neuraminidase (influenza) inhibitor | 0.074 0.031 DBMET00967 0.059 0.055 DBMET00958 | DBMET00967 | |
| 0.006 | 0.524 | 0.065 | Neuraminidase inhibitor | 0.065 0.037 DBMET00967 | DBMET00967 | |
| 0.022 | 0.559 | 0.231 | Platelet antagonist | 0.231 0.081 DBMET00967 0.177 0.12 DBMET00958 | DBMET00967 | |
| 0.07 | 0.615 | 0.637 | Antiinflammatory | 0.637 0.044 DBMET00967 0.628 0.046 DBMET00958 | DBMET00967 | |
| 0.021 | 0.582 | 0.159 | Cell adhesion inhibitor | 0.159 0.041 DBMET00967 0.15 0.047 DBMET00958 | DBMET00967 | |
| 0.016 | 0.585 | 0.233 | Anticoagulant | 0.233 0.043 DBMET00967 0.211 0.049 DBMET00958 | DBMET00967 | |
| 0.011 | 0.596 | 0.07 | Cell adhesion molecule inhibitor | 0.07 0.069 DBMET00967 | DBMET00967 | |
| 0.022 | 0.614 | 0.31 | Hemostatic | 0.31 0.015 DBMET00967 0.202 0.032 DBMET00958 | DBMET00967 | |
| 0.032 | 0.702 | 0.35 | Immunomodulator | 0.35 0.06 DBMET00967 0.271 0.099 DBMET00958 | DBMET00967 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |